Shopping Cart 0
Cart Subtotal
USD 0

Uppsala University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Uppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the areas of ageing related diseases, children's diseases, cancer and other tumor diseases, cardiovascular diseases, behavioural science and ethics, biotechnology and bioinformatics, education research, psychiatry, and others. Uppsala University offers in-service training. The university conducts research in the areas of Biology, Computer Science, Physics, Earth Sciences, Chemistry, Mathematics and Engineering Sciences. It collaborates with the business community regarding both research and direct commercialization of results and ideas. Uppsala University is headquartered in Uppsala, Sweden.

Uppsala University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9

Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Uppsala University, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Beactica Raises Funds through Venture Financing 11

Partnerships 12

BioArctic Enters into Research Collaboration Agreement with Uppsala University 12

BioArctic Enters into Research Agreement with Uppsala University 13

TARIS Biomedical Enters into Research Agreement with Uppsala Clinical Research Center 14

Double Bond Pharma Enters into Agreement with Uppsala University 15

Lidds Enters into Research Agreement with Uppsala University 16

Dicotyledon and Uppsala University Form Joint Venture 17

Licensing Agreements 18

Empros Pharma Enters into Licensing Agreement with Uppsala University 18

Uppsala University-Key Competitors 19

Uppsala University-Key Employees 20

Uppsala University-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Government and Public Interest 22

Jul 02, 2018: Novel Pretargeted Radionuclide Therapy for HER2-Expressing Cancers Shows Promise 22

May 18, 2018: ContextVision deepens collaboration for development of digital lung pathology tool 23

Apr 06, 2018: A new class of antibiotics to combat drug resistance 24

Feb 14, 2018: Karolinska Institutet: Atlas of brain blood vessels provides fresh clues to brain diseases 26

Feb 06, 2018: New technology for accelerated wound healing discovered 27

Jan 18, 2018: New method to stop cells dividing could help fight cancer 28

Jan 17, 2018: New way to stop the growth of breast cancer cells 29

Nov 20, 2017: Oncotarget: Researchers Identify a Potential Molecular Trigger for Invasiveness in Prostate Cancer Cells 30

Oct 31, 2017: University of Copenhagen: Researchers map trends in drug development 31

Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 32

Jul 11, 2017: Shortcut Method in Drug Development 35

May 19, 2017: Mislocalized calcium channel causes insulin secretion defect in diabetes 36

Apr 25, 2017: Potential new treatment for kidney failure in cancer patients 37

Jan 16, 2017: New Research Study Creates New Opportunities for Treating Brain Diseases 38

Product News 39

Jan 12, 2017: Inhibition of EZH2 might be new therapy of multiple myeloma 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Uppsala University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Uppsala University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Uppsala University, Pharmaceuticals & Healthcare, Key Facts 2

Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Uppsala University, Deals By Therapy Area, 2012 to YTD 2018 8

Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9

Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Beactica Raises Funds through Venture Financing 11

BioArctic Enters into Research Collaboration Agreement with Uppsala University 12

BioArctic Enters into Research Agreement with Uppsala University 13

TARIS Biomedical Enters into Research Agreement with Uppsala Clinical Research Center 14

Double Bond Pharma Enters into Agreement with Uppsala University 15

Lidds Enters into Research Agreement with Uppsala University 16

Dicotyledon and Uppsala University Form Joint Venture 17

Empros Pharma Enters into Licensing Agreement with Uppsala University 18

Uppsala University, Key Competitors 19

Uppsala University, Key Employees 20

Uppsala University, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Uppsala University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.